Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Samyang Biopharmaceuticals Corporation
FDA Inspection
•Samyang Biopharmaceuticals Corporation•August 30, 2019

Samyang Biopharmaceuticals Corporation – FDA Inspection, Aug 30, 2019

Record Details

This FDA Inspection record concerns Samyang Biopharmaceuticals Corporation, with an inspection on August 30, 2019, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Samyang Biopharmaceuticals Corporation
Inspection Date
August 30, 2019
Product Type
Human Drugs
Office
Office of Inspections and Investigations
Person
  • Christopher S. Keating
View Company Profile

ID · 7d03fc85-3c3e-4e36-8b00-f2fae9822781

Inspection Facts

Inspection number
1102618
FDA center
Human Drugs
Outcome
Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Samyang Biopharmaceuticals Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.